インスリン原料のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Insulin Raw Material Market Insights, Forecast to 2028

• レポートコード：QY2203B01663 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のインスリン原料の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にインスリン原料の世界市場のxxx％を占める「レギュラーヒトインスリン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「速効型」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のインスリン原料の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのインスリン原料市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのインスリン原料市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 インスリン原料のグローバル主要メーカーには、Novo Nordisk、Sanofi-Aventis、Eli Lilly、Tonghua Dongbao、Ganlee、United Laboratory、Biocon、Amphastar、Wockhardt、Julphar Diabetes、Torrent Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 インスリン原料市場は、種類と用途によって区分されます。世界のインスリン原料市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 レギュラーヒトインスリン、インスリンアナログ 【用途別セグメント】 速効型、中効型、長時間型 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - インスリン原料製品概要 - 種類別市場（レギュラーヒトインスリン、インスリンアナログ） - 用途別市場（速効型、中効型、長時間型） - 調査の目的 ・エグゼクティブサマリー - 世界のインスリン原料販売量予測2017-2028 - 世界のインスリン原料売上予測2017-2028 - インスリン原料の地域別販売量 - インスリン原料の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別インスリン原料販売量 - 主要メーカー別インスリン原料売上 - 主要メーカー別インスリン原料価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（レギュラーヒトインスリン、インスリンアナログ） - インスリン原料の種類別販売量 - インスリン原料の種類別売上 - インスリン原料の種類別価格 ・用途別市場規模（速効型、中効型、長時間型） - インスリン原料の用途別販売量 - インスリン原料の用途別売上 - インスリン原料の用途別価格 ・北米市場 - 北米のインスリン原料市場規模（種類別、用途別） - 主要国別のインスリン原料市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのインスリン原料市場規模（種類別、用途別） - 主要国別のインスリン原料市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のインスリン原料市場規模（種類別、用途別） - 主要国別のインスリン原料市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のインスリン原料市場規模（種類別、用途別） - 主要国別のインスリン原料市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのインスリン原料市場規模（種類別、用途別） - 主要国別のインスリン原料市場規模（トルコ、サウジアラビア） ・企業情報 Novo Nordisk、Sanofi-Aventis、Eli Lilly、Tonghua Dongbao、Ganlee、United Laboratory、Biocon、Amphastar、Wockhardt、Julphar Diabetes、Torrent Pharma ・産業チェーン及び販売チャネル分析 - インスリン原料の産業チェーン分析 - インスリン原料の原材料 - インスリン原料の生産プロセス - インスリン原料の販売及びマーケティング - インスリン原料の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - インスリン原料の産業動向 - インスリン原料のマーケットドライバー - インスリン原料の課題 - インスリン原料の阻害要因 ・主な調査結果

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China. In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.
Market Analysis and Insights: Global Insulin Raw Material Market
Due to the COVID-19 pandemic, the global Insulin Raw Material market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Regular Human Insulin accounting for % of the Insulin Raw Material global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Fast-acting segment is altered to an % CAGR throughout this forecast period.
China Insulin Raw Material market size is valued at US$ million in 2021, while the US and Europe Insulin Raw Material are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Insulin Raw Material landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Insulin Raw Material include Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, Ganlee, United Laboratory, Biocon, Amphastar and Wockhardt, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Insulin Raw Material Scope and Segment
Insulin Raw Material market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Insulin Raw Material market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Regular Human Insulin
Insulin Analogue
Segment by Application
Fast-acting
Intermediate-acting
Long-acting
By Company
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Insulin Raw Material Product Introduction
1.2 Market by Type
1.2.1 Global Insulin Raw Material Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Regular Human Insulin
1.2.3 Insulin Analogue
1.3 Market by Application
1.3.1 Global Insulin Raw Material Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Fast-acting
1.3.3 Intermediate-acting
1.3.4 Long-acting
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Insulin Raw Material Sales Estimates and Forecasts 2017-2028
2.2 Global Insulin Raw Material Revenue Estimates and Forecasts 2017-2028
2.3 Global Insulin Raw Material Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Insulin Raw Material Sales by Region
2.4.1 Global Insulin Raw Material Sales by Region (2017-2022)
2.4.2 Global Sales Insulin Raw Material by Region (2023-2028)
2.5 Global Insulin Raw Material Revenue by Region
2.5.1 Global Insulin Raw Material Revenue by Region (2017-2022)
2.5.2 Global Insulin Raw Material Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Insulin Raw Material Sales by Manufacturers
3.1.1 Global Top Insulin Raw Material Manufacturers by Sales (2017-2022)
3.1.2 Global Insulin Raw Material Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Insulin Raw Material in 2021
3.2 Global Insulin Raw Material Revenue by Manufacturers
3.2.1 Global Insulin Raw Material Revenue by Manufacturers (2017-2022)
3.2.2 Global Insulin Raw Material Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Raw Material Revenue in 2021
3.3 Global Insulin Raw Material Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Insulin Raw Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Insulin Raw Material Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Insulin Raw Material Sales by Type
4.1.1 Global Insulin Raw Material Historical Sales by Type (2017-2022)
4.1.2 Global Insulin Raw Material Forecasted Sales by Type (2023-2028)
4.1.3 Global Insulin Raw Material Sales Market Share by Type (2017-2028)
4.2 Global Insulin Raw Material Revenue by Type
4.2.1 Global Insulin Raw Material Historical Revenue by Type (2017-2022)
4.2.2 Global Insulin Raw Material Forecasted Revenue by Type (2023-2028)
4.2.3 Global Insulin Raw Material Revenue Market Share by Type (2017-2028)
4.3 Global Insulin Raw Material Price by Type
4.3.1 Global Insulin Raw Material Price by Type (2017-2022)
4.3.2 Global Insulin Raw Material Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Insulin Raw Material Sales by Application
5.1.1 Global Insulin Raw Material Historical Sales by Application (2017-2022)
5.1.2 Global Insulin Raw Material Forecasted Sales by Application (2023-2028)
5.1.3 Global Insulin Raw Material Sales Market Share by Application (2017-2028)
5.2 Global Insulin Raw Material Revenue by Application
5.2.1 Global Insulin Raw Material Historical Revenue by Application (2017-2022)
5.2.2 Global Insulin Raw Material Forecasted Revenue by Application (2023-2028)
5.2.3 Global Insulin Raw Material Revenue Market Share by Application (2017-2028)
5.3 Global Insulin Raw Material Price by Application
5.3.1 Global Insulin Raw Material Price by Application (2017-2022)
5.3.2 Global Insulin Raw Material Price Forecast by Application (2023-2028)
6 North America
6.1 North America Insulin Raw Material Market Size by Type
6.1.1 North America Insulin Raw Material Sales by Type (2017-2028)
6.1.2 North America Insulin Raw Material Revenue by Type (2017-2028)
6.2 North America Insulin Raw Material Market Size by Application
6.2.1 North America Insulin Raw Material Sales by Application (2017-2028)
6.2.2 North America Insulin Raw Material Revenue by Application (2017-2028)
6.3 North America Insulin Raw Material Market Size by Country
6.3.1 North America Insulin Raw Material Sales by Country (2017-2028)
6.3.2 North America Insulin Raw Material Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Insulin Raw Material Market Size by Type
7.1.1 Europe Insulin Raw Material Sales by Type (2017-2028)
7.1.2 Europe Insulin Raw Material Revenue by Type (2017-2028)
7.2 Europe Insulin Raw Material Market Size by Application
7.2.1 Europe Insulin Raw Material Sales by Application (2017-2028)
7.2.2 Europe Insulin Raw Material Revenue by Application (2017-2028)
7.3 Europe Insulin Raw Material Market Size by Country
7.3.1 Europe Insulin Raw Material Sales by Country (2017-2028)
7.3.2 Europe Insulin Raw Material Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Insulin Raw Material Market Size by Type
8.1.1 Asia Pacific Insulin Raw Material Sales by Type (2017-2028)
8.1.2 Asia Pacific Insulin Raw Material Revenue by Type (2017-2028)
8.2 Asia Pacific Insulin Raw Material Market Size by Application
8.2.1 Asia Pacific Insulin Raw Material Sales by Application (2017-2028)
8.2.2 Asia Pacific Insulin Raw Material Revenue by Application (2017-2028)
8.3 Asia Pacific Insulin Raw Material Market Size by Region
8.3.1 Asia Pacific Insulin Raw Material Sales by Region (2017-2028)
8.3.2 Asia Pacific Insulin Raw Material Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Insulin Raw Material Market Size by Type
9.1.1 Latin America Insulin Raw Material Sales by Type (2017-2028)
9.1.2 Latin America Insulin Raw Material Revenue by Type (2017-2028)
9.2 Latin America Insulin Raw Material Market Size by Application
9.2.1 Latin America Insulin Raw Material Sales by Application (2017-2028)
9.2.2 Latin America Insulin Raw Material Revenue by Application (2017-2028)
9.3 Latin America Insulin Raw Material Market Size by Country
9.3.1 Latin America Insulin Raw Material Sales by Country (2017-2028)
9.3.2 Latin America Insulin Raw Material Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Insulin Raw Material Market Size by Type
10.1.1 Middle East and Africa Insulin Raw Material Sales by Type (2017-2028)
10.1.2 Middle East and Africa Insulin Raw Material Revenue by Type (2017-2028)
10.2 Middle East and Africa Insulin Raw Material Market Size by Application
10.2.1 Middle East and Africa Insulin Raw Material Sales by Application (2017-2028)
10.2.2 Middle East and Africa Insulin Raw Material Revenue by Application (2017-2028)
10.3 Middle East and Africa Insulin Raw Material Market Size by Country
10.3.1 Middle East and Africa Insulin Raw Material Sales by Country (2017-2028)
10.3.2 Middle East and Africa Insulin Raw Material Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Insulin Raw Material Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novo Nordisk Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Sanofi-Aventis
11.2.1 Sanofi-Aventis Corporation Information
11.2.2 Sanofi-Aventis Overview
11.2.3 Sanofi-Aventis Insulin Raw Material Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi-Aventis Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi-Aventis Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Insulin Raw Material Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eli Lilly Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 Tonghua Dongbao
11.4.1 Tonghua Dongbao Corporation Information
11.4.2 Tonghua Dongbao Overview
11.4.3 Tonghua Dongbao Insulin Raw Material Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Tonghua Dongbao Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Tonghua Dongbao Recent Developments
11.5 Ganlee
11.5.1 Ganlee Corporation Information
11.5.2 Ganlee Overview
11.5.3 Ganlee Insulin Raw Material Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Ganlee Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Ganlee Recent Developments
11.6 United Laboratory
11.6.1 United Laboratory Corporation Information
11.6.2 United Laboratory Overview
11.6.3 United Laboratory Insulin Raw Material Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 United Laboratory Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 United Laboratory Recent Developments
11.7 Biocon
11.7.1 Biocon Corporation Information
11.7.2 Biocon Overview
11.7.3 Biocon Insulin Raw Material Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Biocon Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biocon Recent Developments
11.8 Amphastar
11.8.1 Amphastar Corporation Information
11.8.2 Amphastar Overview
11.8.3 Amphastar Insulin Raw Material Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Amphastar Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Amphastar Recent Developments
11.9 Wockhardt
11.9.1 Wockhardt Corporation Information
11.9.2 Wockhardt Overview
11.9.3 Wockhardt Insulin Raw Material Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Wockhardt Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Wockhardt Recent Developments
11.10 Julphar Diabetes
11.10.1 Julphar Diabetes Corporation Information
11.10.2 Julphar Diabetes Overview
11.10.3 Julphar Diabetes Insulin Raw Material Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Julphar Diabetes Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Julphar Diabetes Recent Developments
11.11 Torrent Pharma
11.11.1 Torrent Pharma Corporation Information
11.11.2 Torrent Pharma Overview
11.11.3 Torrent Pharma Insulin Raw Material Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Torrent Pharma Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Torrent Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Insulin Raw Material Industry Chain Analysis
12.2 Insulin Raw Material Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Insulin Raw Material Production Mode & Process
12.4 Insulin Raw Material Sales and Marketing
12.4.1 Insulin Raw Material Sales Channels
12.4.2 Insulin Raw Material Distributors
12.5 Insulin Raw Material Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Insulin Raw Material Industry Trends
13.2 Insulin Raw Material Market Drivers
13.3 Insulin Raw Material Market Challenges
13.4 Insulin Raw Material Market Restraints
14 Key Findings in The Global Insulin Raw Material Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Insulin Raw Material Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Regular Human Insulin
Table 3. Major Manufacturers of Insulin Analogue
Table 4. Global Insulin Raw Material Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Insulin Raw Material Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Insulin Raw Material Sales by Region (2017-2022) & (Units)
Table 7. Global Insulin Raw Material Sales Market Share by Region (2017-2022)
Table 8. Global Insulin Raw Material Sales by Region (2023-2028) & (Units)
Table 9. Global Insulin Raw Material Sales Market Share by Region (2023-2028)
Table 10. Global Insulin Raw Material Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Insulin Raw Material Revenue Market Share by Region (2017-2022)
Table 12. Global Insulin Raw Material Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Insulin Raw Material Revenue Market Share by Region (2023-2028)
Table 14. Global Insulin Raw Material Sales by Manufacturers (2017-2022) & (Units)
Table 15. Global Insulin Raw Material Sales Share by Manufacturers (2017-2022)
Table 16. Global Insulin Raw Material Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Insulin Raw Material Revenue Share by Manufacturers (2017-2022)
Table 18. Insulin Raw Material Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Insulin Raw Material Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Insulin Raw Material by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Raw Material as of 2021)
Table 21. Insulin Raw Material Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Insulin Raw Material Product Offered
Table 23. Date of Manufacturers Enter into Insulin Raw Material Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Insulin Raw Material Sales by Type (2017-2022) & (Units)
Table 26. Global Insulin Raw Material Sales by Type (2023-2028) & (Units)
Table 27. Global Insulin Raw Material Sales Share by Type (2017-2022)
Table 28. Global Insulin Raw Material Sales Share by Type (2023-2028)
Table 29. Global Insulin Raw Material Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Insulin Raw Material Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Insulin Raw Material Revenue Share by Type (2017-2022)
Table 32. Global Insulin Raw Material Revenue Share by Type (2023-2028)
Table 33. Insulin Raw Material Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Insulin Raw Material Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Insulin Raw Material Sales by Application (2017-2022) & (Units)
Table 36. Global Insulin Raw Material Sales by Application (2023-2028) & (Units)
Table 37. Global Insulin Raw Material Sales Share by Application (2017-2022)
Table 38. Global Insulin Raw Material Sales Share by Application (2023-2028)
Table 39. Global Insulin Raw Material Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Insulin Raw Material Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Insulin Raw Material Revenue Share by Application (2017-2022)
Table 42. Global Insulin Raw Material Revenue Share by Application (2023-2028)
Table 43. Insulin Raw Material Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Insulin Raw Material Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Insulin Raw Material Sales by Type (2017-2022) & (Units)
Table 46. North America Insulin Raw Material Sales by Type (2023-2028) & (Units)
Table 47. North America Insulin Raw Material Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Insulin Raw Material Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Insulin Raw Material Sales by Application (2017-2022) & (Units)
Table 50. North America Insulin Raw Material Sales by Application (2023-2028) & (Units)
Table 51. North America Insulin Raw Material Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Insulin Raw Material Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Insulin Raw Material Sales by Country (2017-2022) & (Units)
Table 54. North America Insulin Raw Material Sales by Country (2023-2028) & (Units)
Table 55. North America Insulin Raw Material Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Insulin Raw Material Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Insulin Raw Material Sales by Type (2017-2022) & (Units)
Table 58. Europe Insulin Raw Material Sales by Type (2023-2028) & (Units)
Table 59. Europe Insulin Raw Material Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Insulin Raw Material Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Insulin Raw Material Sales by Application (2017-2022) & (Units)
Table 62. Europe Insulin Raw Material Sales by Application (2023-2028) & (Units)
Table 63. Europe Insulin Raw Material Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Insulin Raw Material Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Insulin Raw Material Sales by Country (2017-2022) & (Units)
Table 66. Europe Insulin Raw Material Sales by Country (2023-2028) & (Units)
Table 67. Europe Insulin Raw Material Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Insulin Raw Material Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Insulin Raw Material Sales by Type (2017-2022) & (Units)
Table 70. Asia Pacific Insulin Raw Material Sales by Type (2023-2028) & (Units)
Table 71. Asia Pacific Insulin Raw Material Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Insulin Raw Material Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Insulin Raw Material Sales by Application (2017-2022) & (Units)
Table 74. Asia Pacific Insulin Raw Material Sales by Application (2023-2028) & (Units)
Table 75. Asia Pacific Insulin Raw Material Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Insulin Raw Material Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Insulin Raw Material Sales by Region (2017-2022) & (Units)
Table 78. Asia Pacific Insulin Raw Material Sales by Region (2023-2028) & (Units)
Table 79. Asia Pacific Insulin Raw Material Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Insulin Raw Material Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Insulin Raw Material Sales by Type (2017-2022) & (Units)
Table 82. Latin America Insulin Raw Material Sales by Type (2023-2028) & (Units)
Table 83. Latin America Insulin Raw Material Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Insulin Raw Material Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Insulin Raw Material Sales by Application (2017-2022) & (Units)
Table 86. Latin America Insulin Raw Material Sales by Application (2023-2028) & (Units)
Table 87. Latin America Insulin Raw Material Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Insulin Raw Material Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Insulin Raw Material Sales by Country (2017-2022) & (Units)
Table 90. Latin America Insulin Raw Material Sales by Country (2023-2028) & (Units)
Table 91. Latin America Insulin Raw Material Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Insulin Raw Material Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Insulin Raw Material Sales by Type (2017-2022) & (Units)
Table 94. Middle East and Africa Insulin Raw Material Sales by Type (2023-2028) & (Units)
Table 95. Middle East and Africa Insulin Raw Material Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Insulin Raw Material Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Insulin Raw Material Sales by Application (2017-2022) & (Units)
Table 98. Middle East and Africa Insulin Raw Material Sales by Application (2023-2028) & (Units)
Table 99. Middle East and Africa Insulin Raw Material Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Insulin Raw Material Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Insulin Raw Material Sales by Country (2017-2022) & (Units)
Table 102. Middle East and Africa Insulin Raw Material Sales by Country (2023-2028) & (Units)
Table 103. Middle East and Africa Insulin Raw Material Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Insulin Raw Material Revenue by Country (2023-2028) & (US$ Million)
Table 105. Novo Nordisk Corporation Information
Table 106. Novo Nordisk Description and Major Businesses
Table 107. Novo Nordisk Insulin Raw Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Novo Nordisk Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Novo Nordisk Recent Developments
Table 110. Sanofi-Aventis Corporation Information
Table 111. Sanofi-Aventis Description and Major Businesses
Table 112. Sanofi-Aventis Insulin Raw Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Sanofi-Aventis Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Sanofi-Aventis Recent Developments
Table 115. Eli Lilly Corporation Information
Table 116. Eli Lilly Description and Major Businesses
Table 117. Eli Lilly Insulin Raw Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Eli Lilly Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Eli Lilly Recent Developments
Table 120. Tonghua Dongbao Corporation Information
Table 121. Tonghua Dongbao Description and Major Businesses
Table 122. Tonghua Dongbao Insulin Raw Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Tonghua Dongbao Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Tonghua Dongbao Recent Developments
Table 125. Ganlee Corporation Information
Table 126. Ganlee Description and Major Businesses
Table 127. Ganlee Insulin Raw Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Ganlee Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Ganlee Recent Developments
Table 130. United Laboratory Corporation Information
Table 131. United Laboratory Description and Major Businesses
Table 132. United Laboratory Insulin Raw Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. United Laboratory Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. United Laboratory Recent Developments
Table 135. Biocon Corporation Information
Table 136. Biocon Description and Major Businesses
Table 137. Biocon Insulin Raw Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Biocon Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Biocon Recent Developments
Table 140. Amphastar Corporation Information
Table 141. Amphastar Description and Major Businesses
Table 142. Amphastar Insulin Raw Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Amphastar Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Amphastar Recent Developments
Table 145. Wockhardt Corporation Information
Table 146. Wockhardt Description and Major Businesses
Table 147. Wockhardt Insulin Raw Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Wockhardt Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Wockhardt Recent Developments
Table 150. Julphar Diabetes Corporation Information
Table 151. Julphar Diabetes Description and Major Businesses
Table 152. Julphar Diabetes Insulin Raw Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Julphar Diabetes Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Julphar Diabetes Recent Developments
Table 155. Torrent Pharma Corporation Information
Table 156. Torrent Pharma Description and Major Businesses
Table 157. Torrent Pharma Insulin Raw Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Torrent Pharma Insulin Raw Material Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Torrent Pharma Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Insulin Raw Material Distributors List
Table 163. Insulin Raw Material Customers List
Table 164. Insulin Raw Material Market Trends
Table 165. Insulin Raw Material Market Drivers
Table 166. Insulin Raw Material Market Challenges
Table 167. Insulin Raw Material Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Raw Material Product Picture
Figure 3. Global Insulin Raw Material Market Share by Type in 2021 & 2028
Figure 3. Regular Human Insulin Product Picture
Figure 4. Insulin Analogue Product Picture
Figure 5. Global Insulin Raw Material Market Share by Application in 2021 & 2028
Figure 6. Fast-acting
Figure 7. Intermediate-acting
Figure 8. Long-acting
Figure 9. Insulin Raw Material Report Years Considered
Figure 10. Global Insulin Raw Material Sales 2017-2028 (Units)
Figure 11. Global Insulin Raw Material Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Insulin Raw Material Revenue 2017-2028 (US$ Million)
Figure 13. Global Insulin Raw Material Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Insulin Raw Material Sales Market Share by Region (2017-2022)
Figure 15. Global Insulin Raw Material Sales Market Share by Region (2023-2028)
Figure 16. North America Insulin Raw Material Sales YoY (2017-2028) & (Units)
Figure 17. North America Insulin Raw Material Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Insulin Raw Material Sales YoY (2017-2028) & (Units)
Figure 19. Europe Insulin Raw Material Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Insulin Raw Material Sales YoY (2017-2028) & (Units)
Figure 21. Asia-Pacific Insulin Raw Material Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Insulin Raw Material Sales YoY (2017-2028) & (Units)
Figure 23. Latin America Insulin Raw Material Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Insulin Raw Material Sales YoY (2017-2028) & (Units)
Figure 25. Middle East & Africa Insulin Raw Material Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Insulin Raw Material Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Insulin Raw Material in the World: Market Share by Insulin Raw Material Revenue in 2021
Figure 28. Global Insulin Raw Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Insulin Raw Material Sales Market Share by Type (2017-2028)
Figure 30. Global Insulin Raw Material Revenue Market Share by Type (2017-2028)
Figure 31. Global Insulin Raw Material Sales Market Share by Application (2017-2028)
Figure 32. Global Insulin Raw Material Revenue Market Share by Application (2017-2028)
Figure 33. North America Insulin Raw Material Sales Market Share by Type (2017-2028)
Figure 34. North America Insulin Raw Material Revenue Market Share by Type (2017-2028)
Figure 35. North America Insulin Raw Material Sales Market Share by Application (2017-2028)
Figure 36. North America Insulin Raw Material Revenue Market Share by Application (2017-2028)
Figure 37. North America Insulin Raw Material Sales Share by Country (2017-2028)
Figure 38. North America Insulin Raw Material Revenue Share by Country (2017-2028)
Figure 39. United States Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Insulin Raw Material Sales Market Share by Type (2017-2028)
Figure 42. Europe Insulin Raw Material Revenue Market Share by Type (2017-2028)
Figure 43. Europe Insulin Raw Material Sales Market Share by Application (2017-2028)
Figure 44. Europe Insulin Raw Material Revenue Market Share by Application (2017-2028)
Figure 45. Europe Insulin Raw Material Sales Share by Country (2017-2028)
Figure 46. Europe Insulin Raw Material Revenue Share by Country (2017-2028)
Figure 47. Germany Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 48. France Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Insulin Raw Material Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Insulin Raw Material Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Insulin Raw Material Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Insulin Raw Material Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Insulin Raw Material Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Insulin Raw Material Revenue Share by Region (2017-2028)
Figure 58. China Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 61. India Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Insulin Raw Material Sales Market Share by Type (2017-2028)
Figure 68. Latin America Insulin Raw Material Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Insulin Raw Material Sales Market Share by Application (2017-2028)
Figure 70. Latin America Insulin Raw Material Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Insulin Raw Material Sales Share by Country (2017-2028)
Figure 72. Latin America Insulin Raw Material Revenue Share by Country (2017-2028)
Figure 73. Mexico Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Insulin Raw Material Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Insulin Raw Material Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Insulin Raw Material Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Insulin Raw Material Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Insulin Raw Material Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Insulin Raw Material Revenue Share by Country (2017-2028)
Figure 82. Turkey Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Insulin Raw Material Revenue (2017-2028) & (US$ Million)
Figure 85. Insulin Raw Material Value Chain
Figure 86. Insulin Raw Material Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

---